Long-term results of a randomized phase 3 trial comparing idarubicin and daunorubicin in younger patients with acute myeloid leukaemia
Gespeichert in:
| Veröffentlicht in: | Leukemia 2014-02, Vol.28 (2), p.440-443 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 443 |
|---|---|
| container_issue | 2 |
| container_start_page | 440 |
| container_title | Leukemia |
| container_volume | 28 |
| creator | Récher, C Béné, M C Lioure, B Pigneux, A Vey, N Delaunay, J Luquet, I Hunault, M Guyotat, D Bouscary, D Fegueux, N Jourdan, E Lissandre, S Escoffre-Barbe, M Bonmati, C Randriamalala, E Guièze, R Ojeda-Uribe, M Dreyfus, F Harousseau, J L Cahn, J Y Ifrah, N Guardiola, P |
| description | |
| doi_str_mv | 10.1038/leu.2013.290 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_00979453v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A361553680</galeid><sourcerecordid>A361553680</sourcerecordid><originalsourceid>FETCH-LOGICAL-c550t-d71e0208694960028c06d72e9278e926614c51aaceb832131553694c24431a7d3</originalsourceid><addsrcrecordid>eNqFkl1rFDEUhgdR7Fq981oCgig4az4mmcnlUtQKC97odchmzu6mziRjPpT1B_i7zbhtbaUoCQmcPOdNzslbVU8JXhLMujcD5CXFhC2pxPeqBWlaUXPOyf1qgbuurYWkzUn1KMYLjOdD8bA6oQ0RghK-qH6uvdvVCcKIAsQ8pIj8FmkUtOv9aH9Aj6a9joAYSsHqARk_TjpYt0O21yFvrLEOFRj1Ojt_FSjz4LPbQUCTThZc0f1u0x5pkxOg8QCDtz0qb_-iYbT6cfVgq4cITy730-rzu7efzs7r9cf3H85W69pwjlPdtwQwxZ2QjRQY085g0bcUJG27sghBGsOJ1gY2HaOEEc5ZYQ1tGkZ027PT6tVRd68HNQU76nBQXlt1vlqrOYaxbGXD2TdS2JdHdgr-a4aY1GijgWHQDnyOivAiSyST3f_RRkpCCZa0oM__Qi98Dq4UrahoeMs6zvi_qKLVsCIk2j_UTg-grNv6FLSZr1YrJn4X3-FCLe-gyuhL5413sLUlfivhxY2EPegh7aMfcrLexdvg6yNogo8xwPa6pQSr2ZyqfLCazamKOQv-7LKovBmhv4av3FiA-gjEaXYYhBtV3yX4C-W26Wo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1494392367</pqid></control><display><type>article</type><title>Long-term results of a randomized phase 3 trial comparing idarubicin and daunorubicin in younger patients with acute myeloid leukaemia</title><source>MEDLINE</source><source>SpringerLink Journals</source><source>Nature Journals Online</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Récher, C ; Béné, M C ; Lioure, B ; Pigneux, A ; Vey, N ; Delaunay, J ; Luquet, I ; Hunault, M ; Guyotat, D ; Bouscary, D ; Fegueux, N ; Jourdan, E ; Lissandre, S ; Escoffre-Barbe, M ; Bonmati, C ; Randriamalala, E ; Guièze, R ; Ojeda-Uribe, M ; Dreyfus, F ; Harousseau, J L ; Cahn, J Y ; Ifrah, N ; Guardiola, P</creator><creatorcontrib>Récher, C ; Béné, M C ; Lioure, B ; Pigneux, A ; Vey, N ; Delaunay, J ; Luquet, I ; Hunault, M ; Guyotat, D ; Bouscary, D ; Fegueux, N ; Jourdan, E ; Lissandre, S ; Escoffre-Barbe, M ; Bonmati, C ; Randriamalala, E ; Guièze, R ; Ojeda-Uribe, M ; Dreyfus, F ; Harousseau, J L ; Cahn, J Y ; Ifrah, N ; Guardiola, P ; Groupe Ouest-Est d’ étude des Leucé mies Aiguës et autres ; for the Groupe Ouest-Est d’étude des Leucémies Aiguës et autres Maladies du Sang (GOELAMS)</creatorcontrib><identifier>ISSN: 0887-6924</identifier><identifier>EISSN: 1476-5551</identifier><identifier>DOI: 10.1038/leu.2013.290</identifier><identifier>PMID: 24166215</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/699/67/1990/283/1897 ; 692/700/565/1436 ; Acute myeloid leukemia ; Adolescent ; Adult ; Age Factors ; Antineoplastic Combined Chemotherapy Protocols ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Cancer Research ; Chemotherapy ; Comparative analysis ; Critical Care Medicine ; Cytogenetics ; Daunorubicin ; Daunorubicin - administration & dosage ; Dosage and administration ; Drug therapy ; Follow-Up Studies ; Health aspects ; Hematology ; Hematopoietic Stem Cell Transplantation ; Humans ; Idarubicin ; Idarubicin - administration & dosage ; Immunology ; Induction therapy ; Innate immunity ; Intensive ; Internal Medicine ; letter-to-the-editor ; Letters to the editor ; Leukemia ; Leukemia, Myeloid, Acute ; Leukemia, Myeloid, Acute - drug therapy ; Leukemia, Myeloid, Acute - mortality ; Leukemia, Myeloid, Acute - therapy ; Life Sciences ; Medical prognosis ; Medicine ; Medicine & Public Health ; Middle Aged ; Oncology ; Patient outcomes ; Remission (Medicine) ; Remission Induction ; Stem cell transplantation ; Transplantation, Homologous ; Treatment Outcome ; Young Adult</subject><ispartof>Leukemia, 2014-02, Vol.28 (2), p.440-443</ispartof><rights>Macmillan Publishers Limited 2014</rights><rights>COPYRIGHT 2014 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Feb 2014</rights><rights>Macmillan Publishers Limited 2014.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c550t-d71e0208694960028c06d72e9278e926614c51aaceb832131553694c24431a7d3</citedby><cites>FETCH-LOGICAL-c550t-d71e0208694960028c06d72e9278e926614c51aaceb832131553694c24431a7d3</cites><orcidid>0000-0001-7777-5216</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/leu.2013.290$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/leu.2013.290$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24166215$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-00979453$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Récher, C</creatorcontrib><creatorcontrib>Béné, M C</creatorcontrib><creatorcontrib>Lioure, B</creatorcontrib><creatorcontrib>Pigneux, A</creatorcontrib><creatorcontrib>Vey, N</creatorcontrib><creatorcontrib>Delaunay, J</creatorcontrib><creatorcontrib>Luquet, I</creatorcontrib><creatorcontrib>Hunault, M</creatorcontrib><creatorcontrib>Guyotat, D</creatorcontrib><creatorcontrib>Bouscary, D</creatorcontrib><creatorcontrib>Fegueux, N</creatorcontrib><creatorcontrib>Jourdan, E</creatorcontrib><creatorcontrib>Lissandre, S</creatorcontrib><creatorcontrib>Escoffre-Barbe, M</creatorcontrib><creatorcontrib>Bonmati, C</creatorcontrib><creatorcontrib>Randriamalala, E</creatorcontrib><creatorcontrib>Guièze, R</creatorcontrib><creatorcontrib>Ojeda-Uribe, M</creatorcontrib><creatorcontrib>Dreyfus, F</creatorcontrib><creatorcontrib>Harousseau, J L</creatorcontrib><creatorcontrib>Cahn, J Y</creatorcontrib><creatorcontrib>Ifrah, N</creatorcontrib><creatorcontrib>Guardiola, P</creatorcontrib><creatorcontrib>Groupe Ouest-Est d’ étude des Leucé mies Aiguës et autres</creatorcontrib><creatorcontrib>for the Groupe Ouest-Est d’étude des Leucémies Aiguës et autres Maladies du Sang (GOELAMS)</creatorcontrib><title>Long-term results of a randomized phase 3 trial comparing idarubicin and daunorubicin in younger patients with acute myeloid leukaemia</title><title>Leukemia</title><addtitle>Leukemia</addtitle><addtitle>Leukemia</addtitle><subject>692/699/67/1990/283/1897</subject><subject>692/700/565/1436</subject><subject>Acute myeloid leukemia</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Antineoplastic Combined Chemotherapy Protocols</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Cancer Research</subject><subject>Chemotherapy</subject><subject>Comparative analysis</subject><subject>Critical Care Medicine</subject><subject>Cytogenetics</subject><subject>Daunorubicin</subject><subject>Daunorubicin - administration & dosage</subject><subject>Dosage and administration</subject><subject>Drug therapy</subject><subject>Follow-Up Studies</subject><subject>Health aspects</subject><subject>Hematology</subject><subject>Hematopoietic Stem Cell Transplantation</subject><subject>Humans</subject><subject>Idarubicin</subject><subject>Idarubicin - administration & dosage</subject><subject>Immunology</subject><subject>Induction therapy</subject><subject>Innate immunity</subject><subject>Intensive</subject><subject>Internal Medicine</subject><subject>letter-to-the-editor</subject><subject>Letters to the editor</subject><subject>Leukemia</subject><subject>Leukemia, Myeloid, Acute</subject><subject>Leukemia, Myeloid, Acute - drug therapy</subject><subject>Leukemia, Myeloid, Acute - mortality</subject><subject>Leukemia, Myeloid, Acute - therapy</subject><subject>Life Sciences</subject><subject>Medical prognosis</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Oncology</subject><subject>Patient outcomes</subject><subject>Remission (Medicine)</subject><subject>Remission Induction</subject><subject>Stem cell transplantation</subject><subject>Transplantation, Homologous</subject><subject>Treatment Outcome</subject><subject>Young Adult</subject><issn>0887-6924</issn><issn>1476-5551</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkl1rFDEUhgdR7Fq981oCgig4az4mmcnlUtQKC97odchmzu6mziRjPpT1B_i7zbhtbaUoCQmcPOdNzslbVU8JXhLMujcD5CXFhC2pxPeqBWlaUXPOyf1qgbuurYWkzUn1KMYLjOdD8bA6oQ0RghK-qH6uvdvVCcKIAsQ8pIj8FmkUtOv9aH9Aj6a9joAYSsHqARk_TjpYt0O21yFvrLEOFRj1Ojt_FSjz4LPbQUCTThZc0f1u0x5pkxOg8QCDtz0qb_-iYbT6cfVgq4cITy730-rzu7efzs7r9cf3H85W69pwjlPdtwQwxZ2QjRQY085g0bcUJG27sghBGsOJ1gY2HaOEEc5ZYQ1tGkZ027PT6tVRd68HNQU76nBQXlt1vlqrOYaxbGXD2TdS2JdHdgr-a4aY1GijgWHQDnyOivAiSyST3f_RRkpCCZa0oM__Qi98Dq4UrahoeMs6zvi_qKLVsCIk2j_UTg-grNv6FLSZr1YrJn4X3-FCLe-gyuhL5413sLUlfivhxY2EPegh7aMfcrLexdvg6yNogo8xwPa6pQSr2ZyqfLCazamKOQv-7LKovBmhv4av3FiA-gjEaXYYhBtV3yX4C-W26Wo</recordid><startdate>20140201</startdate><enddate>20140201</enddate><creator>Récher, C</creator><creator>Béné, M C</creator><creator>Lioure, B</creator><creator>Pigneux, A</creator><creator>Vey, N</creator><creator>Delaunay, J</creator><creator>Luquet, I</creator><creator>Hunault, M</creator><creator>Guyotat, D</creator><creator>Bouscary, D</creator><creator>Fegueux, N</creator><creator>Jourdan, E</creator><creator>Lissandre, S</creator><creator>Escoffre-Barbe, M</creator><creator>Bonmati, C</creator><creator>Randriamalala, E</creator><creator>Guièze, R</creator><creator>Ojeda-Uribe, M</creator><creator>Dreyfus, F</creator><creator>Harousseau, J L</creator><creator>Cahn, J Y</creator><creator>Ifrah, N</creator><creator>Guardiola, P</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><general>Springer Nature</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0001-7777-5216</orcidid></search><sort><creationdate>20140201</creationdate><title>Long-term results of a randomized phase 3 trial comparing idarubicin and daunorubicin in younger patients with acute myeloid leukaemia</title><author>Récher, C ; Béné, M C ; Lioure, B ; Pigneux, A ; Vey, N ; Delaunay, J ; Luquet, I ; Hunault, M ; Guyotat, D ; Bouscary, D ; Fegueux, N ; Jourdan, E ; Lissandre, S ; Escoffre-Barbe, M ; Bonmati, C ; Randriamalala, E ; Guièze, R ; Ojeda-Uribe, M ; Dreyfus, F ; Harousseau, J L ; Cahn, J Y ; Ifrah, N ; Guardiola, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c550t-d71e0208694960028c06d72e9278e926614c51aaceb832131553694c24431a7d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>692/699/67/1990/283/1897</topic><topic>692/700/565/1436</topic><topic>Acute myeloid leukemia</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Antineoplastic Combined Chemotherapy Protocols</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Cancer Research</topic><topic>Chemotherapy</topic><topic>Comparative analysis</topic><topic>Critical Care Medicine</topic><topic>Cytogenetics</topic><topic>Daunorubicin</topic><topic>Daunorubicin - administration & dosage</topic><topic>Dosage and administration</topic><topic>Drug therapy</topic><topic>Follow-Up Studies</topic><topic>Health aspects</topic><topic>Hematology</topic><topic>Hematopoietic Stem Cell Transplantation</topic><topic>Humans</topic><topic>Idarubicin</topic><topic>Idarubicin - administration & dosage</topic><topic>Immunology</topic><topic>Induction therapy</topic><topic>Innate immunity</topic><topic>Intensive</topic><topic>Internal Medicine</topic><topic>letter-to-the-editor</topic><topic>Letters to the editor</topic><topic>Leukemia</topic><topic>Leukemia, Myeloid, Acute</topic><topic>Leukemia, Myeloid, Acute - drug therapy</topic><topic>Leukemia, Myeloid, Acute - mortality</topic><topic>Leukemia, Myeloid, Acute - therapy</topic><topic>Life Sciences</topic><topic>Medical prognosis</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Oncology</topic><topic>Patient outcomes</topic><topic>Remission (Medicine)</topic><topic>Remission Induction</topic><topic>Stem cell transplantation</topic><topic>Transplantation, Homologous</topic><topic>Treatment Outcome</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Récher, C</creatorcontrib><creatorcontrib>Béné, M C</creatorcontrib><creatorcontrib>Lioure, B</creatorcontrib><creatorcontrib>Pigneux, A</creatorcontrib><creatorcontrib>Vey, N</creatorcontrib><creatorcontrib>Delaunay, J</creatorcontrib><creatorcontrib>Luquet, I</creatorcontrib><creatorcontrib>Hunault, M</creatorcontrib><creatorcontrib>Guyotat, D</creatorcontrib><creatorcontrib>Bouscary, D</creatorcontrib><creatorcontrib>Fegueux, N</creatorcontrib><creatorcontrib>Jourdan, E</creatorcontrib><creatorcontrib>Lissandre, S</creatorcontrib><creatorcontrib>Escoffre-Barbe, M</creatorcontrib><creatorcontrib>Bonmati, C</creatorcontrib><creatorcontrib>Randriamalala, E</creatorcontrib><creatorcontrib>Guièze, R</creatorcontrib><creatorcontrib>Ojeda-Uribe, M</creatorcontrib><creatorcontrib>Dreyfus, F</creatorcontrib><creatorcontrib>Harousseau, J L</creatorcontrib><creatorcontrib>Cahn, J Y</creatorcontrib><creatorcontrib>Ifrah, N</creatorcontrib><creatorcontrib>Guardiola, P</creatorcontrib><creatorcontrib>Groupe Ouest-Est d’ étude des Leucé mies Aiguës et autres</creatorcontrib><creatorcontrib>for the Groupe Ouest-Est d’étude des Leucémies Aiguës et autres Maladies du Sang (GOELAMS)</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Leukemia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Récher, C</au><au>Béné, M C</au><au>Lioure, B</au><au>Pigneux, A</au><au>Vey, N</au><au>Delaunay, J</au><au>Luquet, I</au><au>Hunault, M</au><au>Guyotat, D</au><au>Bouscary, D</au><au>Fegueux, N</au><au>Jourdan, E</au><au>Lissandre, S</au><au>Escoffre-Barbe, M</au><au>Bonmati, C</au><au>Randriamalala, E</au><au>Guièze, R</au><au>Ojeda-Uribe, M</au><au>Dreyfus, F</au><au>Harousseau, J L</au><au>Cahn, J Y</au><au>Ifrah, N</au><au>Guardiola, P</au><aucorp>Groupe Ouest-Est d’ étude des Leucé mies Aiguës et autres</aucorp><aucorp>for the Groupe Ouest-Est d’étude des Leucémies Aiguës et autres Maladies du Sang (GOELAMS)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term results of a randomized phase 3 trial comparing idarubicin and daunorubicin in younger patients with acute myeloid leukaemia</atitle><jtitle>Leukemia</jtitle><stitle>Leukemia</stitle><addtitle>Leukemia</addtitle><date>2014-02-01</date><risdate>2014</risdate><volume>28</volume><issue>2</issue><spage>440</spage><epage>443</epage><pages>440-443</pages><issn>0887-6924</issn><eissn>1476-5551</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>24166215</pmid><doi>10.1038/leu.2013.290</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0001-7777-5216</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0887-6924 |
| ispartof | Leukemia, 2014-02, Vol.28 (2), p.440-443 |
| issn | 0887-6924 1476-5551 |
| language | eng |
| recordid | cdi_hal_primary_oai_HAL_hal_00979453v1 |
| source | MEDLINE; SpringerLink Journals; Nature Journals Online; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | 692/699/67/1990/283/1897 692/700/565/1436 Acute myeloid leukemia Adolescent Adult Age Factors Antineoplastic Combined Chemotherapy Protocols Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cancer Research Chemotherapy Comparative analysis Critical Care Medicine Cytogenetics Daunorubicin Daunorubicin - administration & dosage Dosage and administration Drug therapy Follow-Up Studies Health aspects Hematology Hematopoietic Stem Cell Transplantation Humans Idarubicin Idarubicin - administration & dosage Immunology Induction therapy Innate immunity Intensive Internal Medicine letter-to-the-editor Letters to the editor Leukemia Leukemia, Myeloid, Acute Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - mortality Leukemia, Myeloid, Acute - therapy Life Sciences Medical prognosis Medicine Medicine & Public Health Middle Aged Oncology Patient outcomes Remission (Medicine) Remission Induction Stem cell transplantation Transplantation, Homologous Treatment Outcome Young Adult |
| title | Long-term results of a randomized phase 3 trial comparing idarubicin and daunorubicin in younger patients with acute myeloid leukaemia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T04%3A32%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20results%20of%20a%20randomized%20phase%203%20trial%20comparing%20idarubicin%20and%20daunorubicin%20in%20younger%20patients%20with%20acute%20myeloid%20leukaemia&rft.jtitle=Leukemia&rft.au=R%C3%A9cher,%20C&rft.aucorp=Groupe%20Ouest-Est%20d%E2%80%99%20%C3%A9tude%20des%20Leuc%C3%A9%20mies%20Aigu%C3%ABs%20et%20autres&rft.date=2014-02-01&rft.volume=28&rft.issue=2&rft.spage=440&rft.epage=443&rft.pages=440-443&rft.issn=0887-6924&rft.eissn=1476-5551&rft_id=info:doi/10.1038/leu.2013.290&rft_dat=%3Cgale_hal_p%3EA361553680%3C/gale_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1494392367&rft_id=info:pmid/24166215&rft_galeid=A361553680&rfr_iscdi=true |